Results 11 to 20 of about 749,451 (200)

Evaluation of pharmacokinetics of intravenous protein C concentrate in protein C deficiency: implications for treatment initiation and maintenance [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Dosing of intravenous protein C concentrate (Ceprotin) in patients with protein C deficiency is guided by pharmacokinetics (PK) of plasma protein C activity.
Zhaoyang Li   +3 more
doaj   +3 more sources

Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications

open access: yesBiologics: Targets & Therapy, 2008
Paul N KnoeblDepartment of Medicine 1, Division Hematology and Hemostasis, Medical University of Vienna, Vienna, AustriaAbstract: The protein C pathway has an important function in regulating and modulating blood coagulation and ensuring patency of the ...
Paul N Knoebl
doaj   +1 more source

Comprehensive literature review of protein C concentrate use in patients with severe congenital protein C deficiency [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis
Severe congenital protein C deficiency (SCPCD) is a rare disorder associated with life-threatening purpura fulminans and disseminated intravascular coagulation that typically present within hours after birth.
Csaba Siffel   +6 more
doaj   +2 more sources

Thrombosis-related characteristics of pregnant women with antithrombin deficiency, protein C deficiency and protein S deficiency in Japan [PDF]

open access: yesThrombosis Journal
Background  We previously conducted a primary survey of pregnant women with hereditary thrombophilia based on national surveillance in Japan, but did not examine their thrombosis-related characteristics.
Takao Kobayashi   +5 more
doaj   +2 more sources

Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency [PDF]

open access: yesBiologics: Targets & Therapy, 2010
Sabine Kroiss, Manuela AlbisettiDivision of Hematology, University Children’s Hospital, Zurich, SwitzerlandAbstract: Protein C is one of the major inhibitors of the coagulation system that downregulate thrombin generation.
Sabine Kroiss, Manuela Albisetti
doaj   +2 more sources

Protein C and S deficiency presenting as acute abdomen

open access: yesMedical Journal of Dr. D.Y. Patil University, 2015
Protein C and S are essential in limiting the activation of coagulation in vivo. Their deficiencies predispose the patient to thrombophilia and leads to thrombosis, often at unusual sites. Arterial thrombosis is rarely observed.
Amit A Bharadiya   +3 more
doaj   +2 more sources

Successful Management of Neonatal Purpura Fulminans Caused by Congenital Protein C Deficiency: A Case Report [PDF]

open access: yesJournal of Plastic and Reconstructive Surgery
Neonatal purpura fulminans, often caused by congenital protein C deficiency, presents with rapid onset of skin necrosis and microvascular thrombosis and can progress to disseminated intravascular coagulation.
Makiko Shiraishi, Naoto Yoshioka
doaj   +2 more sources

Surgical treatment of traction retinal detachment associated with compound heterozygous congenital protein C deficiency [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports, 2023
Purpose: Congenital protein C deficiency leads to a prothrombotic state that may result in potentially sight- and life-threatening thromboembolic attacks.
Tomoki Kurihara   +15 more
doaj   +2 more sources

Purpura fulminans due to acquired protein C deficiency

open access: yesIndian Journal of Dermatology, 2015
Purpura fulminans (PF) may be the presenting symptom in a patient with protein C (PC) deficiency. It is a hematological emergency and presents with extensive areas of hemorrhagic necrosis of the skin.
Devdeep Mukherjee   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy